BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 16421740)

  • 1. Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies.
    Fujishiro H; Umegaki H; Isojima D; Akatsu H; Iguchi A; Kosaka K
    Acta Neuropathol; 2006 Feb; 111(2):109-14. PubMed ID: 16421740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.
    Lehéricy S; Hirsch EC; Cervera-Piérot P; Hersh LB; Bakchine S; Piette F; Duyckaerts C; Hauw JJ; Javoy-Agid F; Agid Y
    J Comp Neurol; 1993 Apr; 330(1):15-31. PubMed ID: 8468401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and colocalization of choline acetyltransferase immunoreactivity and NADPH diaphorase reactivity in neurons within the medial septum and diagonal band of Broca in the rat basal forebrain.
    Kitchener PD; Diamond J
    J Comp Neurol; 1993 Sep; 335(1):1-15. PubMed ID: 8408771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related vulnerability of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus.
    Burke MA; Apter JR; Wainer BH; Mufson EJ; Kordower JH
    Exp Neurol; 1994 Aug; 128(2):159-71. PubMed ID: 7521302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies.
    Shepherd CE; McCann H; Thiel E; Halliday GM
    Neurobiol Dis; 2002 Mar; 9(2):249-57. PubMed ID: 11895376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve growth factor receptor expressing human basal forebrain neurons: pathologic alterations in Alzheimer's and Parkinson's disease.
    Mufson EJ; Kordower JH
    Prog Clin Biol Res; 1989; 317():401-14. PubMed ID: 2557638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.
    Hall H; Reyes S; Landeck N; Bye C; Leanza G; Double K; Thompson L; Halliday G; Kirik D
    Brain; 2014 Sep; 137(Pt 9):2493-508. PubMed ID: 25062696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nerve growth factor receptor immunoreactivity in the nonhuman primate (Cebus apella): distribution, morphology, and colocalization with cholinergic enzymes.
    Kordower JH; Bartus RT; Bothwell M; Schatteman G; Gash DM
    J Comp Neurol; 1988 Nov; 277(4):465-86. PubMed ID: 2850304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
    Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
    Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
    Teaktong T; Graham AJ; Court JA; Perry RH; Jaros E; Johnson M; Hall R; Perry EK
    J Neurol Sci; 2004 Oct; 225(1-2):39-49. PubMed ID: 15465084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
    Mufson EJ; Jaffar S; Levey AI
    J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy.
    Schmeichel AM; Buchhalter LC; Low PA; Parisi JE; Boeve BW; Sandroni P; Benarroch EE
    Neurology; 2008 Jan; 70(5):368-73. PubMed ID: 18227417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology.
    Lippa CF; Smith TW; Perry E
    J Neural Transm (Vienna); 1999; 106(5-6):525-35. PubMed ID: 10443555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons.
    Mufson EJ; Bothwell M; Hersh LB; Kordower JH
    J Comp Neurol; 1989 Jul; 285(2):196-217. PubMed ID: 2547849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
    Gilmor ML; Erickson JD; Varoqui H; Hersh LB; Bennett DA; Cochran EJ; Mufson EJ; Levey AI
    J Comp Neurol; 1999 Sep; 411(4):693-704. PubMed ID: 10421878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of estrogen receptor-like immunoreactivity by different subgroups of basal forebrain cholinergic neurons in gonadectomized male and female rats.
    Gibbs RB
    Brain Res; 1996 May; 720(1-2):61-8. PubMed ID: 8782897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in magnetization transfer ratios of the hippocampus between dementia with Lewy bodies and Alzheimer's disease.
    Hanyu H; Shimizu S; Tanaka Y; Kanetaka H; Iwamoto T; Abe K
    Neurosci Lett; 2005 May 20-27; 380(1-2):166-9. PubMed ID: 15854771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease.
    Emre M; Heckers S; Mash DC; Geula C; Mesulam MM
    J Comp Neurol; 1993 Oct; 336(1):117-34. PubMed ID: 8254109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK; Larsen JP; Aarsland D
    Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.
    Albasanz JL; Dalfó E; Ferrer I; Martín M
    Neurobiol Dis; 2005 Dec; 20(3):685-93. PubMed ID: 15949941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.